ACE2 and Diabetic Complications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|26|2730-2735

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.26, 2007-09, pp. : 2730-2735

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atorvastatin and Diabetic Vascular Complications

By  

Current Pharmaceutical Design, Vol. 12, Iss. 12, 2006-04 ,pp. : 1549-1554

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelins in chronic diabetic complications

By Khan Zia Ali   Chakrabarti Subrata  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 6, 2003-06 ,pp. : 622-634

NRC Research Press

Access to resources Recommend Favorite

The Pharmacology of Diabetic Complications

By  

Current Medicinal Chemistry, Vol. 10, Iss. 15, 2003-08 ,pp. : 1317-1327

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoproteins and Diabetic Microvascular Complications

By  

Current Pharmaceutical Design, Vol. 10, Iss. 27, 2004-10 ,pp. : 3395-3418

Bentham Science Publishers

Access to resources Recommend Favorite

ACE and ACE2 in Inflammation: A Tale of Two Enzymes

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 4, 2014-08 ,pp. : 224-234

Bentham Science Publishers

Access to resources Recommend Favorite